Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
$4.59
$4.49
$3.70
$4.85
N/AN/A160 shsN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
$4.10
$4.10
$4.04
$4.10
N/AN/A10,050 shsN/A
SHPMF
Shanghai Pharmaceuticals
$1.21
$1.44
$1.21
$2.08
N/AN/A8,521 shs2,100 shs
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$13.76
+3.3%
$13.30
$11.36
$18.01
N/AN/A13,208 shs16,421 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
0.00%0.00%0.00%+19.84%+14.75%
McKesson Europe AG stock logo
CAKFY
McKesson Europe
0.00%0.00%0.00%0.00%0.00%
SHPMF
Shanghai Pharmaceuticals
0.00%0.00%-18.52%-10.37%-37.63%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
+2.86%+8.74%+5.28%+7.89%-19.12%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/AN/AN/AN/AN/AN/AN/AN/A
SHPMF
Shanghai Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/AN/AN/AN/A
SHPMF
Shanghai Pharmaceuticals
N/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/AN/AN/AN/AN/AN/A
SHPMF
Shanghai Pharmaceuticals
N/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/A0.00N/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/A$0.0947.67N/AN/AN/AN/AN/A
SHPMF
Shanghai Pharmaceuticals
N/A$0.931.30N/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A$4.992.76N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
$0.040.91%N/A43.18%N/A
SHPMF
Shanghai Pharmaceuticals
$0.2621.77%N/A28.26%N/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
0.01%
SHPMF
Shanghai Pharmaceuticals
6.84%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
6,535N/AN/ANot Optionable
McKesson Europe AG stock logo
CAKFY
McKesson Europe
26,329N/AN/ANot Optionable
SHPMF
Shanghai Pharmaceuticals
47,877N/AN/ANot Optionable
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
115,959N/AN/ANot Optionable

CAKFY, ARRJF, SHPMF, and SHTDY Headlines

SourceHeadline
Short Interest in Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Expands By 33.5%Short Interest in Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Expands By 33.5%
americanbankingnews.com - April 15 at 4:56 AM
Sinopharm Group Co LtdSinopharm Group Co Ltd
morningstar.com - April 13 at 12:49 PM
Study: Pfizer vaccine showed strongest immune response in MoroccoStudy: Pfizer vaccine showed strongest immune response in Morocco
msn.com - April 8 at 11:43 AM
Buy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency GainsBuy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency Gains
markets.businessinsider.com - March 27 at 5:36 PM
World’s journalists visit industrial zones in BeijingWorld’s journalists visit industrial zones in Beijing
tehrantimes.com - March 17 at 12:52 AM
Xinhua Silk Road: Electric tricycles made in E. Chinas Rizhao popular abroadXinhua Silk Road: Electric tricycles made in E. China's Rizhao popular abroad
tmcnet.com - March 15 at 6:27 PM
Sinopharm Group Co. - Depositary Receipt () (SHTDY) Price Target Increased by 11.16% to 15.28Sinopharm Group Co. - Depositary Receipt () (SHTDY) Price Target Increased by 11.16% to 15.28
msn.com - February 25 at 12:07 AM
Hong Kong Stocks: Sinopharm to Buyout China-TCM for HK$23.2BHong Kong Stocks: Sinopharm to Buyout China-TCM for HK$23.2B
msn.com - February 22 at 2:53 PM
Pharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034: VisiongainPharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034: Visiongain
uk.finance.yahoo.com - February 21 at 2:12 PM
Chorionic Gonadotrophin for Injection Market Spectrum: Applications, Trends, And Key Players In The Chorionic Gonadotrophin for Injection MarketChorionic Gonadotrophin for Injection Market Spectrum: Applications, Trends, And Key Players In The Chorionic Gonadotrophin for Injection Market
opprairie.com - February 21 at 2:12 PM
Sinopharm Group Co Ltd ADRSinopharm Group Co Ltd ADR
thestreet.com - February 19 at 1:13 PM
Navigating Through The Penicillin G Potassium First Crystals Market LandscapeNavigating Through The Penicillin G Potassium First Crystals Market Landscape
opprairie.com - February 18 at 8:39 PM
Clonazepam API Market Booming With Top Key Players Executing Different Strategies And PlansClonazepam API Market Booming With Top Key Players Executing Different Strategies And Plans
opprairie.com - January 30 at 1:06 PM
Sinopharm Group Co Ltd ADR SHTDYSinopharm Group Co Ltd ADR SHTDY
morningstar.com - November 7 at 7:27 AM
Local transmission of monkeypox virus in Beijing has been significantly suppressed: Chinese CDCLocal transmission of monkeypox virus in Beijing has been significantly suppressed: Chinese CDC
globaltimes.cn - October 15 at 2:02 PM
Sinopharms mRNA vaccines can provide effective protection against monkeypox: studySinopharm's mRNA vaccines can provide effective protection against monkeypox: study
globaltimes.cn - September 25 at 1:29 PM
Hong Kong stocks slide amid China property default risk while Sinopharm slides on index debut, LOccitane crashesHong Kong stocks slide amid China property default risk while Sinopharm slides on index debut, L'Occitane crashes
finance.yahoo.com - September 5 at 7:08 AM
Cefaclor Capsules Market to Expand with Strong Development by 2029 – China Union Chempharma, Sinopharm, AGP Limited, Carlsbad TechnologyCefaclor Capsules Market to Expand with Strong Development by 2029 – China Union Chempharma, Sinopharm, AGP Limited, Carlsbad Technology
puyalluppost.com - June 28 at 10:05 AM
WHO recommends updating COVID shots to add XBB.1 variantsWHO recommends updating COVID shots to add XBB.1 variants
msn.com - May 18 at 3:28 PM
Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in ChinaEndurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China
asiaone.com - April 17 at 5:26 PM
Chlorpheniramine Maleate Market Outlook and Forecast till 2031Chlorpheniramine Maleate Market Outlook and Forecast till 2031
marketwatch.com - March 30 at 10:21 AM
Sinopharm’s Earnings Slightly Better Than ExpectedSinopharm’s Earnings Slightly Better Than Expected
morningstar.com - March 29 at 7:25 PM
2023-2029 Gold(III) Bromide (AuBr3) Market Size and Industrial Overview with Region Footprint | Latest Report by Absolute Reports2023-2029 Gold(III) Bromide (AuBr3) Market Size and Industrial Overview with Region Footprint | Latest Report by Absolute Reports
marketwatch.com - March 29 at 4:22 AM
7-Aminocephalosporanic Acid (7-ACA) Market Outlook By 20317-Aminocephalosporanic Acid (7-ACA) Market Outlook By 2031
marketwatch.com - March 28 at 10:26 PM

Company Descriptions

Arjo AB (publ) logo

Arjo AB (publ)

OTCMKTS:ARRJF
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.
McKesson Europe logo

McKesson Europe

OTCMKTS:CAKFY
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.

Shanghai Pharmaceuticals

OTCMKTS:SHPMF
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Sinopharm Group logo

Sinopharm Group

OTCMKTS:SHTDY
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.